Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer

Soozana Puvanenthiran; Sharadah Essapen; Ben Haagsma; Izhar Bagwan; Margaret Green; Said Abdullah Khelwatty; Alan Seddon; Helmout Modjtahedi

doi:10.18632/oncotarget.24791

Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer

Soozana Puvanenthiran, Sharadah Essapen, Ben Haagsma, Izhar Bagwan, Margaret Green, Said Abdullah Khelwatty, Alan Seddon, Helmout Modjtahedi

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	19662-19674
Journal	Oncotarget
Volume	9
DOIs	https://doi.org/10.18632/oncotarget.24791
Publication status	Published - 13 Apr 2018

Keywords

Biological sciences

Access to Document

10.18632/oncotarget.24791

Puvanenthiran-S-40813-VoRFinal published version, 3.26 MBLicence: CC BY

https://doi.org/10.18632/oncotarget.24791

Cite this

@article{19bbcc8bd5f44c789ece481c89793bd3,

title = "Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer",

keywords = "Biological sciences",

author = "Soozana Puvanenthiran and Sharadah Essapen and Ben Haagsma and Izhar Bagwan and Margaret Green and Khelwatty, \{Said Abdullah\} and Alan Seddon and Helmout Modjtahedi",

year = "2018",

month = apr,

day = "13",

doi = "10.18632/oncotarget.24791",

language = "English",

volume = "9",

pages = "19662--19674",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

}

TY - JOUR

T1 - Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer

AU - Puvanenthiran, Soozana

AU - Essapen, Sharadah

AU - Haagsma, Ben

AU - Bagwan, Izhar

AU - Green, Margaret

AU - Khelwatty, Said Abdullah

AU - Seddon, Alan

AU - Modjtahedi, Helmout

PY - 2018/4/13

Y1 - 2018/4/13

KW - Biological sciences

U2 - 10.18632/oncotarget.24791

DO - 10.18632/oncotarget.24791

M3 - Article

SN - 1949-2553

VL - 9

SP - 19662

EP - 19674

JO - Oncotarget

JF - Oncotarget

ER -